SPEMBLY MEDICAL LIMITED
Get an alert when SPEMBLY MEDICAL LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
—
Latest balance sheet
Net assets
£9.3m
-0.3% vs 2024
Employees
—
Average over period
Profit before tax
-£30k
-100.3% lowest in 3 filed years
Net assets
3-year trend · vs Health Care median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £0 | £0 | — | — | |
| Operating profit | £0 | £0 | — | — | |
| Profit before tax | £0 | £9,500,000 | -£29,877 | -100.3% | |
| Net profit | £0 | £9,500,000 | -£29,877 | -100.3% | |
| Cash | — | — | — | — | |
| Total assets less current liabilities | £9,368,696 | £9,368,696 | £9,338,819 | -0.3% | |
| Net assets | £9,368,696 | £9,368,696 | £9,338,819 | -0.3% | |
| Equity | £9,368,696 | £9,368,696 | £9,338,819 | -0.3% | |
| Average employees | 0 | 0 | — | — | |
| Wages | — | — | — | — | |
| Directors' remuneration | £0 | £0 | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Return on capital employed | 0.0% | 0.0% | — | |
| Gearing (liabilities / total assets) | 0.0% | 0.0% | 0.0% | |
| Current ratio | 10.62x | — | — |
Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 6 times since incorporation
- SPEMBLY MEDICAL LIMITED 2003-03-12 → present
- INTEGRA NEUROSCIENCES LIMITED 2000-07-28 → 2003-03-12
- NMT NEUROSCIENCES (UK) LIMITED 1998-07-13 → 2000-07-28
- ELEKTA INSTRUMENTS LIMITED 1997-02-17 → 1998-07-13
- SURGICAL TECHNOLOGY GROUP LIMITED 1991-03-21 → 1997-02-17
- MARCH MEDICAL PLC 1987-03-10 → 1991-03-21
- JORRABAN (NO.12) PUBLIC LIMITED COMPANY 1987-01-07 → 1987-03-10
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- BDO LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“On the basis of their assessment of the Company's financial position and resources, the directors have concluded that there is no intention to liquidate the Company and there is no material uncertainty with respect to the Company's going concern and that the Company has adequate resources to continue in operational existence for the foreseeable future and not less than 12 months from the date of approval of the financial statements.”
Group structure
- SPEMBLY MEDICAL LIMITED · parent
- Integra NeuroSciences Limited 100%
- Integra LifeSciences Austria GmbH 100%
- Integra LifeSciences Spain SL 100%
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 22 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| CSC CLS (UK) LIMITED | Corporate Secretary | 2025-08-27 | — | — |
| MOSEBROOK, Jeffrey Alan | Director | 2017-11-13 | Oct 1976 | American |
| SWISS, Timothy Scott | Director | 2022-10-28 | May 1980 | American |
Show 22 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| HENNEMAN III, John Bell | Secretary | 2000-04-05 | 2005-07-01 |
| HOWE, Graham John | Secretary | 1999-06-09 | 2000-04-05 |
| SINYARD, Steven Barry | Secretary | — | 1999-06-09 |
| CORPORATION SERVICE COMPANY (UK) LIMITED | Corporate Secretary | 2022-12-20 | 2025-08-27 |
| OLSWANG COSEC LIMITED | Corporate Secretary | 2005-07-01 | 2022-12-20 |
| ARDUINI, Peter Joseph | Director | 2012-02-01 | 2017-11-13 |
| CHAZANOVITZ, David Allen | Director | 1998-07-08 | 2000-04-05 |
| EMANY, Sravan Kumar | Director | 2019-02-01 | 2021-12-03 |
| ESSIG, Stuart Martin | Director | 2000-04-05 | 2012-02-01 |
| GIBSON, Peter Frederick | Director | — | 1999-02-10 |
| GLUECK, Neal Jay | Director | 2014-03-03 | 2019-01-04 |
| GORELICK, Richard Dean | Director | 2014-03-03 | 2017-11-13 |
| HENNEMAN III, John Bell | Director | 2000-04-05 | 2014-03-04 |
| HURTAK, Wenzel | Director | 2007-02-05 | 2013-03-21 |
| KNIGHT, William Joseph | Director | 1998-10-05 | 2000-04-05 |
| LEKSELL, Laurent | Director | — | 1998-07-08 |
| MARKLUND, Bjorn | Director | — | 1995-03-23 |
| PINCUS, Theodore Irwin | Director | 1998-07-08 | 1998-10-05 |
| SINYARD, Steven Barry | Director | — | 2000-04-05 |
| SPARKES, Patrick Nigel | Director | 1999-06-09 | 2007-01-31 |
| TULLY, Thomas Malcolm | Director | 1998-07-08 | 2000-04-05 |
| VON CELSING, Hans | Director | — | 1998-07-08 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Integra Lifesciences Holdings Corporation | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2023-12-23 | Active |
| Caveangle Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2020-12-21 | Ceased 2023-12-23 |
| Integra Neurosciences Holdings (Uk) Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Ceased 2020-12-21 |
Filing timeline
Last 20 of 247 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-09-11 | AA | accounts | Accounts with accounts type full | |
| 2026-05-20 | AD02 | address | Change sail address company with old address new address | |
| 2026-01-09 | AD04 | address | Move registers to registered office company with new address | |
| 2026-01-06 | CH01 | officers | Change person director company with change date | |
| 2025-10-01 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-09-11 | AA | accounts | Accounts with accounts type full | |
| 2025-09-10 | TM02 | officers | Termination secretary company with name termination date | |
| 2025-09-10 | AD01 | address | Change registered office address company with date old address new address | |
| 2025-09-10 | AP04 | officers | Appoint corporate secretary company with name date | |
| 2024-10-02 | AA | accounts | Accounts with accounts type full | |
| 2024-09-30 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-09-16 | RP04CS01 | confirmation-statement | Second filing of confirmation statement with made up date | |
| 2024-09-06 | PSC02 | persons-with-significant-control | Notification of a person with significant control | |
| 2024-09-06 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2024-05-30 | TM02 | officers | Termination secretary company with name termination date | |
| 2023-10-10 | AA | accounts | Accounts with accounts type full | |
| 2023-09-18 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-02-14 | AP04 | officers | Appoint corporate secretary company with name date | |
| 2023-02-09 | AD01 | address | Change registered office address company with date old address new address | |
| 2023-02-09 | AP01 | officers | Appoint person director company with name date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 5
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.